Interleukin-15 interactions with interleukin-15 receptor complexes: Characterization and species specificity

被引:59
作者
Eisenman, J
Ahdieh, M
Beers, C
Brasel, K
Kennedy, MK
Le, T
Bonnert, TP
Paxton, RJ
Park, LS
机构
[1] Immunex Res & Dev Corp, Dept Prot Chem, Seattle, WA 98101 USA
[2] Immunex Res & Dev Corp, Dept Biochem, Seattle, WA 98101 USA
[3] Immunex Res & Dev Corp, Dept Mol Biol, Seattle, WA 98101 USA
关键词
human; IL-15; mutants; IL-2; receptor; mouse; species specificity;
D O I
10.1006/cyto.2002.1989
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin (IL-) 2 and IL-15 share the IL-2 receptor betagamma(c) subunits (IL-2Rbetagamma(c)) but have specific, unique a receptor subunits. We studied species specificity of human (hu), simian (si), and mouse (mu) IL-15 and found that hu and A IL-15 behaved similarly in all systems investigated. Hu and mu IL-15 bound hu or mu IL-15Ralpha with equal high affinity in the presence or absence of IL-2Rbetagamma(c), and exhibited similar proliferative activities on cells containing all three subunits. However, quantitative differences were noted in the specific activity of hu and mu IL-15 in both in vitro and in vivo systems utilizing IL-2Rbetagamma(c) in the absence of IL-15Ralpha. These data show that hu IL-15 may be used in mouse model systems, however care must be taken when comparing the efficacy and toxicity of cytokines across species. (C) 2002 Elsevier science Ltd. All rights reserved.
引用
收藏
页码:121 / 129
页数:9
相关论文
共 30 条
[21]   INTERLEUKIN-15 AND THE GROWTH OF TUMOR-DERIVED ACTIVATED T-CELLS [J].
LEWKO, WM ;
SMITH, TL ;
BOWMAN, DJ ;
GOOD, RW ;
OLDHAM, RK .
CANCER BIOTHERAPY, 1995, 10 (01) :13-20
[22]   The alpha chain of the IL-2 receptor determines the species specificity of high-affinity IL-2 binding [J].
Liu, KD ;
Greene, WC ;
Goldsmith, MA .
CYTOKINE, 1996, 8 (08) :613-621
[23]   IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation [J].
Lodolce, JP ;
Boone, DL ;
Chai, S ;
Swain, RE ;
Dassopoulos, T ;
Trettin, S ;
Ma, A .
IMMUNITY, 1998, 9 (05) :669-676
[24]  
MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245
[25]  
MOSMANN TR, 1987, J IMMUNOL, V138, P1813
[26]   STUDIES EVALUATING THE ANTITUMOR-ACTIVITY AND TOXICITY OF INTERLEUKIN-15, A NEW T-CELL GROWTH-FACTOR - COMPARISON WITH INTERLEUKIN-2 [J].
MUNGER, W ;
DEJOY, SQ ;
JEYASEELAN, R ;
TORLEY, LW ;
GRABSTEIN, KH ;
EISENMANN, J ;
PAXTON, R ;
COX, T ;
WICK, MM ;
KERWAR, SS .
CELLULAR IMMUNOLOGY, 1995, 165 (02) :289-293
[27]   DIFFERENCES IN THE INTERLEUKIN-2 (IL-2) RECEPTOR SYSTEM IN HUMAN AND MOUSE - ALPHA-CHAIN IS REQUIRED FOR FORMATION OF THE FUNCTIONAL-MOUSE IL-2 RECEPTOR [J].
NEMOTO, T ;
TAKESHITA, T ;
ISHII, N ;
KONDO, M ;
HIGUCHI, M ;
SATOMI, S ;
NAKAMURA, M ;
MORI, S ;
SUGAMURA, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) :3001-3005
[28]  
Pettit DK, 1997, J BIOL CHEM, V272, P2312
[29]   CLONING OF THE GAMMA-CHAIN OF THE HUMAN IL-2 RECEPTOR [J].
TAKESHITA, T ;
ASAO, H ;
OHTANI, K ;
ISHII, N ;
KUMAKI, S ;
TANAKA, N ;
MUNAKATA, H ;
NAKAMURA, M ;
SUGAMURA, K .
SCIENCE, 1992, 257 (5068) :379-382
[30]   CHEMOATTRACTION OF HUMAN BLOOD T-LYMPHOCYTES BY INTERLEUKIN-15 [J].
WILKINSON, PC ;
LIEW, FY .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :1255-1259